EMG
AMPH icon

Ellington Management Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Ellington Management Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-17,500
Closed -$210K – 264
2016
Q1 		$210K Buy
+17,500
New +$206K 0.09% 373

Other funds holding AMPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ellington Management Group's AMPH Position: Q2 2016 in Review

Ellington Management Group sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2016, closing a stake of 17,500 shares — an estimated $210K sold.

Ellington Management Group first reported a position in AMPH in Q1 2016 and held it in 1 quarter. The position peaked at $210K in Q1 2016. 104 funds tracked by Wall St. Rank hold AMPH as of Q2 2016.

  • Ellington Management Group reported no remaining Amphastar Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Ellington Management Group sold 17,500 Amphastar Pharmaceuticals shares in Q2 2016, an estimated $210K.
  • Ellington Management Group first reported a position in Amphastar Pharmaceuticals in Q1 2016 and held it in 1 quarter.
  • Ellington Management Group's Amphastar Pharmaceuticals position peaked at $210K in Q1 2016.
  • 104 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2016.

Based on Ellington Management Group's 13F filing for Q2 2016, filed 15 Aug 2016.